Aims & Scope

Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal.

It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field.

Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases.

The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools.

Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed.

Experimental & Molecular Medicine is an open access, online-only journal.

Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Cancer biology Immunology Neuroscience Cardiovascular biology Genetics and genomics Gene therapy Metabolic diseases Stem cells and regenerative medicine Physiology and diseases Molecular Medicine.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 12.9
2024 9.50

SJR (SCImago Journal Rank)

Year Value
2024 4.001

Quartile

Year Value
2024 Q1

h-index

Year Value
2024 133

Journal Rank

Year Value
2024 423

Journal Citation Indicator

Year Value
2024 7101

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


Quick Facts

Current Factor
12.9
First Published: 2025

SJR (SCImago Journal Rank)

SJR
4.001
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields